<bill session="116" type="s" number="640" updated="2020-02-12T16:41:27Z">
  <state datetime="2019-03-04">REFERRED</state>
  <status>
    <introduced datetime="2019-03-04"/>
  </status>
  <introduced datetime="2019-03-04"/>
  <titles>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes.</title>
    <title type="short" as="introduced">Phair Pricing Act of 2019</title>
    <title type="short" as="introduced">Phair Pricing Act of 2019</title>
    <title type="display">Phair Pricing Act of 2019</title>
  </titles>
  <sponsor bioguide_id="K000393"/>
  <cosponsors>
    <cosponsor bioguide_id="B001243" joined="2019-05-22"/>
    <cosponsor bioguide_id="B001236" joined="2019-06-04"/>
    <cosponsor bioguide_id="C001047" joined="2019-05-21"/>
    <cosponsor bioguide_id="C001035" joined="2019-07-18"/>
    <cosponsor bioguide_id="C001095" joined="2019-05-22"/>
    <cosponsor bioguide_id="C001096" joined="2019-05-23"/>
    <cosponsor bioguide_id="E000295" joined="2019-07-16"/>
    <cosponsor bioguide_id="H001079" joined="2019-05-22"/>
    <cosponsor bioguide_id="J000300" joined="2019-09-24"/>
    <cosponsor bioguide_id="L000575" joined="2019-06-18"/>
    <cosponsor bioguide_id="M001183" joined="2019-06-04"/>
    <cosponsor bioguide_id="P000612" joined="2019-05-22"/>
    <cosponsor bioguide_id="T000464" joined="2019-05-22"/>
    <cosponsor bioguide_id="W000437" joined="2019-06-04"/>
  </cosponsors>
  <actions>
    <action datetime="2019-03-04">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-03-04" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="identical" number="1034"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care quality"/>
    <term name="Health information and medical records"/>
    <term name="Inflation and prices"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2019-03-04T05:00:00Z" status="Introduced in Senate">Phair Pricing Act of 2019

This bill requires that certain negotiated prices for covered drugs under the Medicare prescription drug benefit be disclosed at the point-of-sale.

Specifically, negotiated prices offered under a prescription drug plan (PDP) must be disclosed at the point-of-sale; the disclosed price must include specified adjustments, payments, and fees that are negotiated with the pharmacy (e.g., dispensing fees) by the PDP sponsor or pharmacy benefit manager.

Additionally, the Centers for Medicare &amp; Medicaid Services must establish certain quality measures for PDP sponsors to use when determining incentive payments and adjustments (e.g., performance payments) to pharmacies.</summary>
  <committee-reports/>
</bill>
